TERRY KINNEY: Open Payments
NPI 1194869883 · RED BLUFF, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 69 payments from 11 companies in 2025. Trend: 2023 $492 · 2024 $807 · 2025 $1,642
Food & beverage: $1,531Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $370 |
| Janssen Pharmaceuticals, Inc | 6 | $216 |
| E.R. Squibb & Sons, L.L.C. | 5 | $210 |
| Otsuka America Pharmaceutical, Inc. | 10 | $187 |
| Alkermes, Inc. | 9 | $187 |
| Neurocrine BioSciences, Inc. | 9 | $172 |
| Braeburn Inc. | 5 | $122 |
| Lundbeck LLC | 4 | $80 |
| Janssen Scientific Affairs, LLC | 2 | $52 |
| ABBVIE INC. | 1 | $26 |
Products named: INVEGA SUSTENNA, COBENFY, ARISTADA, INGREZZA, REXULTI, BRIXADI, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
